Multicenter Interspecialty Consensus on Experimental Oncology Drug-Related Ocular Adverse Event Reporting.
Saved in:
| Title: | Multicenter Interspecialty Consensus on Experimental Oncology Drug-Related Ocular Adverse Event Reporting. |
|---|---|
| Authors: | Pasricha ND; Department of Ophthalmology, University of California, San Francisco.; Francis I. Proctor Foundation, University of California, San Francisco., Kim SK; Department of Ophthalmology, University of Texas Health Science Center, Houston., Farooq AV; Department of Ophthalmology and Visual Science, University of Chicago Medical Center, Chicago, Illinois., Lindgren ES; Department of Ophthalmology, University of California, San Francisco., Yan R; Department of Ophthalmology, University of California, San Francisco., Seitzman GD; Department of Ophthalmology, University of California, San Francisco.; Francis I. Proctor Foundation, University of California, San Francisco., Chan MF; Department of Ophthalmology, University of California, San Francisco.; Francis I. Proctor Foundation, University of California, San Francisco., Shantha JG; Francis I. Proctor Foundation, University of California, San Francisco., Skondra D; Department of Ophthalmology and Visual Science, University of Chicago Medical Center, Chicago, Illinois., Jeng BH; Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia., Chamberlain WD; Casey Eye Institute, Oregon Health & Science University, Portland., Colby KA; Department of Ophthalmology, New York University Grossman School of Medicine, New York University Langone Health, New York., Goldstein DA; Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Sobrin L; Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston., Kim IK; Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston., Singh K; Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, California., Chambers WA; Department of Ophthalmology, George Washington University, School of Medicine and Health Sciences, Washington, DC., Boyd WM; Division of Ophthalmology, Office of Specialty Medicine, US Food and Drug Administration, Silver Spring, Maryland., Silverstein J; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles., Pohlmann PR; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Lu J; Division of Hematology and Oncology, Department of Medicine, Northwestern University Freiberg School of Medicine, Chicago, Illinois., Glencer AC; Department of Surgery, University of California, San Francisco., Huppert LA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco., Chien AJ; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco., Rugo HS; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco., Esserman LJ; Department of Surgery, University of California, San Francisco.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco. |
| Source: | JAMA ophthalmology [JAMA Ophthalmol] 2026 Jan 01; Vol. 144 (1), pp. 62-68. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN: 2168-6173 (Electronic) Linking ISSN: 21686165 NLM ISO Abbreviation: JAMA Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6173 |
|---|---|
| DOI: | 10.1001/jamaophthalmol.2025.3159 |
